SteelPeak Wealth’s GSK GSK Stock Holding History

SteelPeak Wealth’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-7,985	Closed	-$238K	–	446
2022 Q3	$238K	Buy	+7,985	New	+$303K	0.02%	351
2022 Q2	–	Sell	-4,434	Closed	-$241K	–	436
2022 Q1	$241K	Buy	4,434 +196	+5%	+$10.6K	0.01%	375
2021 Q4	$234K	Buy	4,238 +54	+1%	+$2.81K	0.01%	366
2021 Q3	$200K	Buy	4,184 +53	+1%	+$2.66K	0.01%	396
2021 Q2	$206K	Sell	4,131 -354	-8%	-$17K	0.01%	395
2021 Q1	$200K	Buy	4,485 +13	+0.3%	+$590	0.02%	353
2020 Q4	$206K	Sell	4,472 -60	-1%	-$2.76K	0.02%	300
2020 Q3	$213K	Buy	4,532 +100	+2%	+$5.01K	0.02%	247
2020 Q2	$226K	Sell	4,432 -18	-0.4%	-$923	0.03%	219
2020 Q1	$211K	Sell	4,450 -280	-6%	-$14.9K	0.03%	206
2019 Q4	$278K	Buy	+4,730	New	+$263K	0.04%	206

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

SteelPeak Wealth's GSK Position: Q4 2022 in Review

SteelPeak Wealth sold out of GSK (GSK) in Q4 2022, closing a stake of 7,985 shares — an estimated $238K sold.

SteelPeak Wealth first reported a position in GSK in Q4 2019 and held it in 11 quarters. The position peaked at $278K in Q4 2019. 813 funds tracked by Wall St. Rank hold GSK as of Q4 2022.

SteelPeak Wealth reported no remaining GSK position as of Q4 2022 after selling out during the quarter.
SteelPeak Wealth sold 7,985 GSK shares in Q4 2022, an estimated $238K.
SteelPeak Wealth first reported a position in GSK in Q4 2019 and held it in 11 quarters.
SteelPeak Wealth's GSK position peaked at $278K in Q4 2019.
813 funds tracked by Wall St. Rank held GSK as of Q4 2022.

Based on SteelPeak Wealth's 13F filing for Q4 2022, filed 25 Jan 2023.